Fundraising Fox

ITM

Founded 2004 · 653 employees on LinkedIn · 1 known investors

ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio. The company manufactures and supplies medical radioisotopes including Lutetium-177 and Actinium-225 for cancer detection and treatment.

BiotechHealthtechMedical Devices

Founders & leadership

APAlexander Pironi
Alexander PironiinExecutive Vice President, Global Head of Radioisotopes
DK
Dr. Konstantin ZhernosekovChief Scientific Officer & Managing Director ITM Medical Isotopes & ITM Oncologics

Investors · 1

Nextech InvestZurich · $648K – $3.2M

In the news

ITM Power (LSE:ITM) Turns Public Funding Into a Hydrogen Manufacturing Testskalkinemedia.com · Aug 2026ITM Semiconductor Co., Ltd. announced that it has received KRW 20 billion in funding from Mirae Asset Securities Co., Ltd. and other advised investors. | MarketScreenermarketscreener.com · Jul 2026ITM Power’s funding backdrop is improving, but investors still want proofad-hoc-news.de · Jul 2026ITM Radiopharma– ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Fundsitm-radiopharma.com · May 2025ITM Radiopharma: ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturingitm-radiopharma.com · Jun 2024ITM Raises €188M in Fundingfinsmes.com · Jun 2024

Frequently asked questions

What does ITM do?
ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio. The company manufactures and supplies medical radioisotopes including Lutetium-177 and Actinium-225 for cancer detection and treatment.
Who are ITM's investors?
ITM's investors include Nextech Invest.